1. Home
  2. CAG vs COGT Comparison

CAG vs COGT Comparison

Compare CAG & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$14.93

Market Cap

6.9B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$38.95

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAG
COGT
Founded
1919
2014
Country
United States
United States
Employees
26100
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.6B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CAG
COGT
Price
$14.93
$38.95
Analyst Decision
Hold
Strong Buy
Analyst Count
17
15
Target Price
$16.88
$36.21
AVG Volume (30 Days)
13.5M
2.0M
Earning Date
04-01-2026
05-06-2026
Dividend Yield
9.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,500,000,000.00
$7,871,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,733.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.53
$10.38
52 Week High
$20.32
$43.73

Technical Indicators

Market Signals
Indicator
CAG
COGT
Relative Strength Index (RSI) 53.59 51.49
Support Level $13.66 $36.38
Resistance Level $16.07 $40.67
Average True Range (ATR) 0.54 1.93
MACD -0.00 -0.19
Stochastic Oscillator 54.29 39.88

Price Performance

Historical Comparison
CAG
COGT

About CAG ConAgra Brands Inc.

Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: